Psych Editorial
  • Home
  • Contact

Meet the Pfizer Executive Leadership Team: Anthony J. Maddaluna

Meet the Pfizer Executive Leadership Team: Anthony J. Maddaluna

Anthony J. Maddaluna was named President in January 2011. Prior to that time, he was Senior Vice President, PGM Strategy and Supply Network Transformation, with overall responsibility for PGM’s supply network transformation strategy. Under Tony’s leadership in that position, PGM focused on plant network strategy, capturing global advantage, Agile/Lean operations, business process redesign, technology and innovation and other enterprise-wide initiatives. Tony’s career with Pfizer spans more than 35 years. He joined the Company in 1975 in St. Louis, Missouri, serving in the Minerals, Pigments and Metals (MPM) division in several positions, including Production Supervisor. From 1978 to 1983, he held various engineering positions in the Adams, Massachusetts, MPM division and subsequently worked in the Pharmaceutical division as Manager, Technical Training. In 1985, Tony relocated to Terre Haute, Indiana, where he held various positions before becoming Plant Manager. In 1994, he moved to Pfizer’s Barceloneta, Puerto Rico, plant as General Manager. He was named Vice President/Team Leader, Europe in 1998 and also had responsibility for Global Logistics, Global Operations Team and Strategic Planning during a portion of this time. He was named Vice President, Strategy & Supply Network Transformation in 2008, and Senior Vice President in 2009. Prior to joining Pfizer, Tony worked at the U.S. Environmental Protection Agency and at Johnson & Johnson as an engineer.

Tony represents Pfizer on the National Association of Manufacturers (NAM) and, beginning in 2013, will be a member of the NAM Executive Committee.

Tony holds a B.S. in Chemical Engineering from Northeastern University and an M.B.A. in Management and Organization Development from Southern Illinois University.

Source: Pfizer Press Releases – Meet Our Executive

Related Posts

Takeda Pharmaceuticals

Takeda and Lundbeck Announce FDA Approval of Brintellix™ (vortioxetine) for Treatment of Adults with Major Depressive Disorder

Eli Lilly and Co., Executive Bios

Meet the Executive Eli Lilly and Company Leadership Team: Fionnuala M. Walsh

Eli Lilly and Co., Executive Bios

Meet the Executive Eli Lilly and Company Leadership Team: Jacques Tapiero

News & Views

  • Now Accepting Content
  • Takeda and Lundbeck Announce FDA Approval of Brintellix™ (vortioxetine) for Treatment of Adults with Major Depressive Disorder
  • Introducing the New Kid on the Block to Treat Depression: “Brintellix”.
  • Meet the Executive Eli Lilly and Company Leadership Team: Fionnuala M. Walsh
  • Meet the Executive Eli Lilly and Company Leadership Team: Jacques Tapiero
Psych Editorial
Copyright © PhysicianEditorial.com
All Rights Reserved!